KCDC Risk Assessments on the Initial Phase of the COVID-19 Outbreak in Korea
This study aims to evaluate the risk assessments of coronavirus 2019 (COVID-19) in the Korea Centers for Disease Control and Prevention (KCDC), from the point of detection to the provision of basic information to the relevant public health authorities. To estimate the overall risk of specific public...
Saved in:
Published in | Osong public health and research perspectives Vol. 11; no. 2; pp. 67 - 73 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korea Centers for Disease Control and Prevention
01.04.2020
Korea Disease Control and Prevention Agency 질병관리본부 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study aims to evaluate the risk assessments of coronavirus 2019 (COVID-19) in the Korea Centers for Disease Control and Prevention (KCDC), from the point of detection to the provision of basic information to the relevant public health authorities.
To estimate the overall risk of specific public health events, probability, and impact at the country-level were evaluated using available information. To determine the probability of particular public health events, the risk of importation and risk of transmission were taken into consideration. KCDC used 5 levels ("very low," "low," "moderate," "high," and "very high") for each category and overall risk was eventually decided.
A total of 8 risk assessments were performed on 8 separate occasions between January 8
to February 28
, 2020, depending on the detection and report of COVID-19 cases in other countries. The overall risk of the situation in each assessment increased in severity over this period: "low" (first), "moderate" (second), "high" (third), "high" (fourth), "high" (fifth), "high" (sixth), "high" (seventh), and "very high" (eighth).
The KCDC's 8 risk assessments were utilized to activate national emergency response mechanisms and eventually prepare for the pandemic to ensure the containment and mitigation of COVID-19 with non-pharmaceutical public health measures. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://ophrp.org/journal/view.php?number=547 |
ISSN: | 2210-9099 2233-6052 2210-9110 |
DOI: | 10.24171/j.phrp.2020.11.2.02 |